Syros Pharmaceuticals, Inc. (SYRS): Company Current Liabilities

SYRS (Syros Pharmaceuticals) - company brandmark

This chart of Syros Pharmaceuticals (SYRS) stock quotes on the GURU.Markets platform, where the metric stands at 0.00, reflects the impact of global logistics and scientific disruptions on drug development timelines. However, the humanitarian status of medicine minimizes sanction risks, ensuring stable Western partnerships. The business foundation relies on a robust patent portfolio and strategic alliances that support capital until the company becomes a cash generator.

SYRS Syros Pharmaceuticals, Inc. Company Short-Term Loans and Borrowings (07/04/2022 - 03/29/2025)

Metric breakdowns and analytics for Syros Pharmaceuticals, Inc (SYRS)

- current quotes and average value forecast:
Price Chart Syros Pharmaceuticals, Inc.|SYRS - Analyst Median Target
- stock exchange capitalization data:
Market Valuation Syros Pharmaceuticals, Inc.|SYRS - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Syros Pharmaceuticals|SYRS - Accounting Value of Company|Market Value to Book Value Ratio syros.com|SYRS - Company Assets
- debt and liquidity details:
Debt to Equity Syros Pharmaceuticals|SYRS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Syros Pharmaceuticals|SYRS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Syros Pharmaceuticals, Inc.|SYRS - Long-Term Liabilities|Company Short-Term Debts Syros Pharmaceuticals|Quick Ratio syros.com
- earnings and multiples data:
SYRS - Net Profit
General company analysis:SYRS - Syros Pharmaceuticals, Inc.
Mass-produced product of syros.com

Short-term liability dynamics serve as a key liquidity indicator, determining the issuer's ability to service debts within a year without compromising operational stability. By analyzing the short-term debt trajectory, an investor assesses the financial leverage of Syros Pharmaceuticals (SYRS), which funds external CROs for genomic testing, balancing investments in innovation against credit load risks.

Key competitors

TEM - Company Short-Term Debt|Short-Term Debt Volume Qiagen NV QGEN|IONS (Ionis Pharma) - Company Current Liabilities|Short-Term Debt Repligen Inc. (RGEN)|Company Short-Term Debt Avidity Biosciences|CRSP: Company Short-Term Loans and Borrowings|Company Short-Term Debt GeneDx (WGS)|RARE - Short-Term Debt|Company Short-Term Debt Beam Therapeutics Corp BEAM|Short-Term Debt Volume Sarepta Corp (SRPT)|TWST: Company Current Liabilities|Company Short-Term Loans and Borrowings TXG (10xgenomics.com)|Intellia Therapeutics, Inc. (NTLA) - Company Short-Term Debt|Current Liabilities STOK (Stoke Therapeutics Inc)|BLFS (BioLife Corp) - Company Short-Term Debts|WVE: Company Short-Term Loans and Borrowings|Company Short-Term Debts MAZE|Company Short-Term Debts sionnatx.com (SION)|Company Short-Term Debt Prime Medicine PRME|Company Short-Term Loans and Borrowings TSHA|QURE - Company Short-Term Debt|MeiraGTx Corp (MGTX) - Company Current Liabilities|RGNX: Company Short-Term Debts|solidbio.com (SLDB) - Company Short-Term Debts|OCGN (Ocugen) - Company Short-Term Debts|Company Current Liabilities Pacific Biosciences of California, Inc. (PACB)|Company Short-Term Debts BNTC|DSGN - Short-Term Debt|Rocket Pharmaceuticals - Company Current Liabilities|Company Short-Term Debts 4dmoleculartherapeutics.com FDMT|LXEO: Company Current Liabilities|Korro Bio, Inc. - Amount of Current Liabilities|EDIT: Company Short-Term Debts|SLN - Short-Term Debt Volume|PRQR (ProQR) - Company Short-Term Debts|Company Current Liabilities Codexis Bio (CDXS)|Company Short-Term Debts SGMO|Company Short-Term Debts nautilus.bio (NAUT)|Company Short-Term Debt Metagenomi, Inc MGX|precisionbiosciences.com - Company Short-Term Debt|GBIO - Company Short-Term Debt|Short-Term Debt Volume boundlessbio.com BOLD|exicuretx.com (XCUR) - Company Short-Term Debt|IMNN - Short-Term Debt Volume|Company Current Liabilities PHIO|Short-Term Debt Mustang Bio Corp MBIO|Company Short-Term Debt TransCode Therapeutics (RNAZ)|BNGO (bionanogenomics.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Applied DNA Sciences, Inc. APDN|Short-Term Debt Volume bluebird bio Inc. (BLUE)|ImmunoPrecise - Company Short-Term Debts|OMGA (Omega Therapeutics Corp) - Company Short-Term Indebtedness|Singular Genomics Systems (OMIC) - Company Short-Term Debt|Company Short-Term Indebtedness RGLS|TBIO (Telesis Bio) - Company Short-Term Debts|Company Short-Term Debts TRACON Pharmaceuticals Inc.|Company Short-Term Debt Unity Bio (UBX)